Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 243 (LINC00243) is a human long non-coding RNA (lncRNA) located on chromosome 6 that does not encode a protein but functions in gene regulation. LINC00243 is upregulated in non-small cell lung cancer (NSCLC), where it promotes cell proliferation and glycolysis by acting as a molecular sponge for miR-507, leading to the upregulation of PDK4. High expression of LINC00243 is associated with poor prognosis in NSCLC, suggesting potential utility as a prognostic biomarker. There is currently no evidence that LINC00243 is a traditional therapeutic target such as a receptor, enzyme, or transporter[1][2][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 243 (LINC00243).